Leaflet DARONRIX 30mcg / ml injection suspension
Indicated for: prevention of influenza
Route of administration: injectable
Substance: pandemic flu vaccine (vaccine)
ATC: J07BB01 (Antiinfectives for systemic use | Viral vaccines | Influenza vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The pandemic influenza vaccine is used to prevent infections caused by influenza virus strains that have triggered a pandemic. This type of vaccine is rapidly developed during a pandemic based on the responsible virus strain, such as H1N1 (swine flu) in 2009.
The vaccine contains inactivated viral antigens or protein subunits that stimulate the immune system to produce specific antibodies against the pandemic strain. It is administered intramuscularly, usually in one or two doses, depending on public health recommendations.
The vaccine is intended for the general population, with priority given to high-risk groups such as healthcare workers, individuals with chronic illnesses, and the elderly.
Common side effects include pain at the injection site, mild fever, fatigue, and muscle aches. The pandemic influenza vaccine is an essential measure for controlling the spread of the virus during a pandemic and reducing associated mortality and morbidity.
General data about DARONRIX 30mcg / ml
- Substance: pandemic flu vaccine
- Date of latest medicines list: 01-07-2013
- Product code: W51935008
- Concentration: 30mcg / ml
- Pharmaceutical form: injection suspension
- Quantity: 50
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for pandemic flu vaccine
Concentrations available for pandemic flu vaccine
- 15mcg/ml
- 30mcg/ml